Director/PDMR Shareholding | RNS | Ticker

/News/RNS

Director/PDMR Shareholding

RNS Announcement

RNS Number : 8804F

GlaxoSmithKline PLC

01 August 2016

GlaxoSmithKline plc (the 'Company')

Transaction notification

Details of PDMR/person closely associated with them ('PCA')

Name

Ms C Thomas

Position/status

Senior Vice President, Human Resources

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

The exercise of options over 20,180 Ordinary Shares, granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan.

Price(s) and

volume(s)

Price(s)	Volume(s)
£11.47	20,180

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-07-28

Place of the transaction

n/a

Details of PDMR/person closely associated with them ('PCA')

Name

Ms C Thomas

Position/status

Senior Vice President, Human Resources

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Sale of 17,024 Ordinary Shares to satisfy option costs and the tax and NI liability arising following the exercise of options over 20,180 Ordinary Shares granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan.

Price(s) and

volume(s)

Price(s)	Volume(s)
£17.0778	17,024

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-07-28

Place of the transaction

London Stock Exchange (XLON)

Details of PDMR/person closely associated with them ('PCA')

Name

Ms C Thomas

Position/status

Senior Vice President, Human Resources

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

The exercise of options over 20,180 Ordinary Shares, granted on 20 February 2007 under the GlaxoSmithKline Share Option Plan.

Price(s) and

volume(s)

Price(s)	Volume(s)
£14.88	20,180

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-07-28

Place of the transaction

n/a

Details of PDMR/person closely associated with them ('PCA')

Name

Ms C Thomas

Position/status

Senior Vice President, Human Resources

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Sale of 19,235 Ordinary Shares to satisfy option costs and the tax and NI liability arising following the exercise of options over 20,180 Ordinary Shares granted on 20 February 2007 under the GlaxoSmithKline Share Option Plan.

Price(s) and

volume(s)

Price(s)	Volume(s)
£17.0814	19,235

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-07-28

Place of the transaction

London Stock Exchange (XLON)

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHZFLFBQVFLBBB

RNS metadata

Title: Director/PDMR Shareholding
Time: 16:26:42
Date: 1 Aug 2016
Category: Director/PDMR dealings
ID: 8804F